Skip to main content
Engy Vigneron on Muck Rack

Engy Vigneron

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Engy

Contact Engy, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

PPARα-mediated lipid metabolism reprogramming supports anti-EGFR therapy resistance in head and neck squamous cell carcinoma - Nature Communications

|
By Hannah Zaryouh, Cedric van Marcke, Lionel Mignion, Bénédicte F. Jordan, Léo Aubert, Romain Boidot, Yvan Larondelle, Olivier Feron, Engy Vigneron, Elise Y. Lepicard, Olivier Lowyck, Manon Desgres, Guido T. Bommer
| Nature Verified
Abstract Anti-epidermal growth factor receptor (EGFR) therapy (cetuximab) shows a limited clinical benefit for patients with locally advanced or recurrent/metastatic head and neck squamous cell carcinoma (HNSCC), due to the frequent occurrence of secondary resistance mechanisms.
Open in Who Shared Issue with article?
See all 1 articles